These therapeutic findings strongly suggest that PCOS and PCOS-like traits require ongoing hyperandrogenic action mediated through AR at the hypothalamo-pituitary and/or ovarian levels to maintain PCOS pathophysiology. Here, AR is linked to polycystic ovary syndrome.